pubmed-article:12745588 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12745588 | lifeskim:mentions | umls-concept:C0082420 | lld:lifeskim |
pubmed-article:12745588 | lifeskim:mentions | umls-concept:C1366583 | lld:lifeskim |
pubmed-article:12745588 | lifeskim:mentions | umls-concept:C0014257 | lld:lifeskim |
pubmed-article:12745588 | lifeskim:mentions | umls-concept:C0023467 | lld:lifeskim |
pubmed-article:12745588 | lifeskim:mentions | umls-concept:C0162597 | lld:lifeskim |
pubmed-article:12745588 | lifeskim:mentions | umls-concept:C0016030 | lld:lifeskim |
pubmed-article:12745588 | lifeskim:mentions | umls-concept:C0205245 | lld:lifeskim |
pubmed-article:12745588 | lifeskim:mentions | umls-concept:C1521970 | lld:lifeskim |
pubmed-article:12745588 | lifeskim:mentions | umls-concept:C0205409 | lld:lifeskim |
pubmed-article:12745588 | lifeskim:mentions | umls-concept:C0678558 | lld:lifeskim |
pubmed-article:12745588 | lifeskim:mentions | umls-concept:C1881379 | lld:lifeskim |
pubmed-article:12745588 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:12745588 | pubmed:dateCreated | 2003-5-14 | lld:pubmed |
pubmed-article:12745588 | pubmed:abstractText | In vitro cultures of BM cells from newly diagnosed patients with AML displayed a defective BM stromal compartment, with a reduced number of fibroblast-colony-forming unit (CFU-F: 1 +/- 1.25 SD) and a decreased proliferative ability. The purposes of our study were: 1). to select BM mesenchymal stem cells (MSC) and BM-derived stromal cells (BMDSCs) from AML patients at diagnosis and from healthy subjects, using an immunomagnetic system and either anti-CD105 or anti-fibroblast MAbs; 2). to study the immunophenotypic and functional properties of freshly isolated and cultured mesenchymal cells; 3). to test the in vitro plasticity of the selected cells to differentiate towards an endothelial phenotype. | lld:pubmed |
pubmed-article:12745588 | pubmed:language | eng | lld:pubmed |
pubmed-article:12745588 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12745588 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12745588 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12745588 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12745588 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12745588 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12745588 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12745588 | pubmed:issn | 1465-3249 | lld:pubmed |
pubmed-article:12745588 | pubmed:author | pubmed-author:HofmannTT | lld:pubmed |
pubmed-article:12745588 | pubmed:author | pubmed-author:CastoldiG LGL | lld:pubmed |
pubmed-article:12745588 | pubmed:author | pubmed-author:LanzaFF | lld:pubmed |
pubmed-article:12745588 | pubmed:author | pubmed-author:MorettiSS | lld:pubmed |
pubmed-article:12745588 | pubmed:author | pubmed-author:PauliSS | lld:pubmed |
pubmed-article:12745588 | pubmed:author | pubmed-author:HorwitzEE | lld:pubmed |
pubmed-article:12745588 | pubmed:author | pubmed-author:CampioniDD | lld:pubmed |
pubmed-article:12745588 | pubmed:author | pubmed-author:DominiciMM | lld:pubmed |
pubmed-article:12745588 | pubmed:author | pubmed-author:PunturieriMM | lld:pubmed |
pubmed-article:12745588 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12745588 | pubmed:volume | 5 | lld:pubmed |
pubmed-article:12745588 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12745588 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12745588 | pubmed:pagination | 66-79 | lld:pubmed |
pubmed-article:12745588 | pubmed:dateRevised | 2008-4-24 | lld:pubmed |
pubmed-article:12745588 | pubmed:meshHeading | pubmed-meshheading:12745588... | lld:pubmed |
pubmed-article:12745588 | pubmed:meshHeading | pubmed-meshheading:12745588... | lld:pubmed |
pubmed-article:12745588 | pubmed:meshHeading | pubmed-meshheading:12745588... | lld:pubmed |
pubmed-article:12745588 | pubmed:meshHeading | pubmed-meshheading:12745588... | lld:pubmed |
pubmed-article:12745588 | pubmed:meshHeading | pubmed-meshheading:12745588... | lld:pubmed |
pubmed-article:12745588 | pubmed:meshHeading | pubmed-meshheading:12745588... | lld:pubmed |
pubmed-article:12745588 | pubmed:meshHeading | pubmed-meshheading:12745588... | lld:pubmed |
pubmed-article:12745588 | pubmed:meshHeading | pubmed-meshheading:12745588... | lld:pubmed |
pubmed-article:12745588 | pubmed:meshHeading | pubmed-meshheading:12745588... | lld:pubmed |
pubmed-article:12745588 | pubmed:meshHeading | pubmed-meshheading:12745588... | lld:pubmed |
pubmed-article:12745588 | pubmed:meshHeading | pubmed-meshheading:12745588... | lld:pubmed |
pubmed-article:12745588 | pubmed:meshHeading | pubmed-meshheading:12745588... | lld:pubmed |
pubmed-article:12745588 | pubmed:meshHeading | pubmed-meshheading:12745588... | lld:pubmed |
pubmed-article:12745588 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:12745588 | pubmed:articleTitle | Functional and immunophenotypic characteristics of isolated CD105(+) and fibroblast(+) stromal cells from AML: implications for their plasticity along endothelial lineage. | lld:pubmed |
pubmed-article:12745588 | pubmed:affiliation | Department of Biomedical Sciences and Advanced Therapies University Hospital, Ferrara, Italy. | lld:pubmed |
pubmed-article:12745588 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12745588 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |